- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT02197624
Genetic Variants and Iron Absorption
21 de julio de 2014 actualizado por: Cornell University
Metabolic Adaptation to Plant-based Diets in Asian Populations
The two specific aims of this study are: 1) to assess the impact of a genetic variant on iron status; 2) to assess the impact of a genetic variant on non-heme absorption among Asian women.
The investigators hypothesize that the genetic variant could enhance iron status and iron absorption in Asian women.
Descripción general del estudio
Estado
Terminado
Condiciones
Descripción detallada
To determine the HFE genotype of female Asian study volunteers, we collected venous blood samples and extracted DNA from these blood samples.
HFE genotype was determined as CC, CT, and TT and used to assess possible differences in iron status as a function of genotype.
To measure the impact of genotype on non-heme Fe absorption, a sub-group of women with the CC (n=10) or TT (n=11) genotype were invited to return for an Fe absorption study.
Each volunteer consumed stable 57Fe (as ferrous sulfate).
Two weeks after ingesting this tracer, a blood sample was collected from each woman and the amount of non-heme (57Fe) iron incorporated into red blood cells was measured with magnetic sector thermal ionization mass spectrometry.
Possible associations between iron status and iron absorption as a function of genotypes were explored.
Data from this study will provide information that aims to improve human health by better understanding the iron requirements of individuals with different genetic background.
Tipo de estudio
De observación
Inscripción (Actual)
57
Contactos y Ubicaciones
Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.
Ubicaciones de estudio
-
-
New York
-
Ithaca, New York, Estados Unidos, 14853
- Human Metabolic Research Unit, Cornell University
-
-
Criterios de participación
Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.
Criterio de elegibilidad
Edades elegibles para estudiar
18 años a 35 años (Adulto)
Acepta Voluntarios Saludables
Sí
Géneros elegibles para el estudio
Femenino
Método de muestreo
Muestra no probabilística
Población de estudio
Women were eligible for the study if they met the following criteria: 1) non-pregnant and between the ages of 18~35 y; 2) of East Asian descent with both maternal and paternal grandparents from East Asia, including China, Japan, South Korea, Vietnam, Thailand, Malaysia and Singapore; 3) not taking any vitamin or mineral supplements for at least 1 month before the study and during the 2-week study interval; 4) no pre-existing medical problems including malabsorption, blood disorders, ulcers, joint diseases or asthma that might impact inflammation or Fe status; 5) not taking any prescribed medications known to affect iron homeostasis.
Descripción
Inclusion Criteria:
- non-pregnant and between the ages of 18~35 y
- East Asian descent with both maternal and paternal grandparents from East Asia, including China, Japan, South Korea, Vietnam, Thailand, Malaysia and Singapore
Exclusion Criteria:
- taking or planing to take any vitamin or mineral supplements during the study period
- pre-existing medical problems that might impact inflammation or Fe status, including malabsorption, blood disorders, ulcers, joint diseases and asthma
- taking any prescribed medications known to affect iron homeostasis
Plan de estudios
Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.
¿Cómo está diseñado el estudio?
Detalles de diseño
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
---|---|---|
Genotype at SNP rs9366637
Periodo de tiempo: 2 weeks after the participant's visit to the laboratory
|
At the participant's visit to the laboratory, a 10 mL blood sample was collected.
The blood sample was used for determining genotype.
|
2 weeks after the participant's visit to the laboratory
|
Hemoglobin
Periodo de tiempo: Up to 2 days after the participant's visit to the laboratory
|
At the participant's visit to the laboratory, a 10 mL blood sample was collected.
The blood sample was used for determining the concentration of hemoglobin.
|
Up to 2 days after the participant's visit to the laboratory
|
Serum Ferritin
Periodo de tiempo: Up to 6 months after the participant's visit to the laboratory
|
At the participant's visit to the laboratory, a 10 mL blood sample was collected.
The blood sample was used for determining the concentration of serum ferritin.
|
Up to 6 months after the participant's visit to the laboratory
|
Serum transferrin receptor
Periodo de tiempo: Up to 6 months after the participant's visit to the laboratory
|
At the participant's visit to the laboratory, a 10 mL blood sample was collected.
The blood sample was used for determining the concentration of serum transferrin receptor.
|
Up to 6 months after the participant's visit to the laboratory
|
Non-heme Iron absorption in women with 2 HFE genotypes
Periodo de tiempo: one month for screening with genotype then 2 weeks for iron absorption study
|
Women donated a blood sample for genotyping.
Women with particular HFE genotypes were invited to return for an absorption study.
Two weeks after women consume the iron tracer, a blood sample was obtained to measure the amount of iron absorbed.
|
one month for screening with genotype then 2 weeks for iron absorption study
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
---|---|---|
Folate
Periodo de tiempo: Up to 6 months after the participant's visit to the laboratory
|
At the participant's visit to the laboratory, a 10 mL blood sample was collected.
The blood sample was used for determining the concentration of folate.
|
Up to 6 months after the participant's visit to the laboratory
|
Vitamin B-12
Periodo de tiempo: Up to 6 months after the participant's visit to the laboratory
|
At the participant's visit to the laboratory, a 10 mL blood sample was collected.
The blood sample was used for determining the concentration of vitamin B-12.
|
Up to 6 months after the participant's visit to the laboratory
|
C-reactive protein
Periodo de tiempo: Up to 6 months after the participant's visit to the laboratory
|
At the participant's visit to the laboratory, a 10 mL blood sample was collected.
The blood sample was used for determining the concentration of C-reactive protein.
|
Up to 6 months after the participant's visit to the laboratory
|
Colaboradores e Investigadores
Aquí es donde encontrará personas y organizaciones involucradas en este estudio.
Patrocinador
Fechas de registro del estudio
Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.
Fechas importantes del estudio
Inicio del estudio
1 de junio de 2012
Finalización primaria (Actual)
1 de abril de 2013
Finalización del estudio (Actual)
1 de mayo de 2014
Fechas de registro del estudio
Enviado por primera vez
16 de julio de 2014
Primero enviado que cumplió con los criterios de control de calidad
21 de julio de 2014
Publicado por primera vez (Estimar)
23 de julio de 2014
Actualizaciones de registros de estudio
Última actualización publicada (Estimar)
23 de julio de 2014
Última actualización enviada que cumplió con los criterios de control de calidad
21 de julio de 2014
Última verificación
1 de julio de 2014
Más información
Términos relacionados con este estudio
Palabras clave
Otros números de identificación del estudio
- IRB #: 1206003117
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .